About Antigenix Therapeutics
Antigenix Therapeutics is a private company based in Princeton, New Jersey, incorporated in 2024 in Delaware. It has reported $3,363,695 raised in one offering on Form D since October 2025. Its chief executive is Christopher Whitfield.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2025 | Oct 24, 2025 | $3,363,695of $8.3M target | 17 | $197K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Antigenix Therapeutics's Form D filed Oct 24, 2025.
